Aqueous Two-Phase System for 3D Cell Spheroid Stability

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Conventional two-dimensional cancer cell cultures are inadequate for accurately modeling drug responses in vivo due to limitations in the hanging drop method, such as small drop size, evaporation issues, osmotic pressure changes, manual handling errors, and sensitivity to physical movements, which hinder reliable and high-throughput drug screening.

Innovation Solution

An aqueous two-phase system comprising an immersion aqueous polymer phase and a droplet of a droplet aqueous polymer phase is used to create three-dimensional cellular spheroids, allowing cells to self-assemble and maintain stable cultures for extended periods without evaporation concerns, enabling precise drug administration and monitoring.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Shape

If the hanging drop method is used to produce cancer cell spheroids, then three-dimensional cell aggregates can be formed, but evaporation occurs due to small drop size leading to increased osmotic pressure and compromised cell morphology

Engineering Contradiction:
Improvethree-dimensional cell aggregateVSAvoidevaporation and osmotic pressure change
Core Design Contradiction:
ShapeVSObject-affected harmful factors

Solution Approach 1:

The patent embeds a droplet containing cells and media within a larger continuous phase, creating a nested structure where the inner droplet is surrounded by outer media. This nested configuration allows the inner droplet to maintain its three-dimensional cell aggregate structure while being protected from evaporation by the surrounding medium, thus resolving the contradiction between forming 3D spheroids and preventing evaporation-induced osmotic stress

Inventive Principle:
Principle #7Nested doll (Nesting)

Solution Approach 2:

The patent introduces an intermediary medium (continuous phase) that acts as a barrier between the inner droplet and the external environment. This intermediary layer prevents direct evaporation from the inner droplet while allowing nutrient and waste exchange, thereby maintaining stable osmotic pressure and preventing the harmful effects of evaporation on cell morphology

Inventive Principle:
Principle #24Intermediary (Mediator)

2Productivity

If manual pipetting is used to refresh media in hanging drops, then media exchange can be performed, but errors occur such as aspirating out spheroids or introducing shear stress to cells

Engineering Contradiction:
Improvemedia refresh capabilityVSAvoidspheroid integrity and cell viability
Core Design Contradiction:
ProductivityVSReliability

Solution Approach 1:

The patent replaces manual pipetting with an automated liquid handling system that can precisely exchange media in the nested droplet structure. The automated system avoids the mechanical errors of manual operation (aspirating spheroids or applying shear stress) while maintaining the ability to refresh media, thus improving both reliability and productivity

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The nested droplet structure enables the system to serve itself by allowing automated media exchange without manual intervention. The structure facilitates self-contained media refresh operations that can be performed robotically, eliminating human error while maintaining media exchange capability

Inventive Principle:
Principle #25Self-service

3Shape

If hanging drop method is used, then spheroids can be formed, but the system is sensitive to physical movements causing detachment of drops and spheroids

Engineering Contradiction:
Improvespheroid formationVSAvoidattachment to surface
Core Design Contradiction:
ShapeVSStability of the object's composition

Solution Approach 1:

The patent merges the spheroid formation function with the attachment function by creating a nested structure where the inner droplet containing spheroids is embedded within an outer media phase that is attached to the substrate. This combination ensures that the spheroids remain stable and attached through the outer media layer, preventing detachment from physical movements while maintaining three-dimensional structure

Inventive Principle:
Principle #5Merging (Combining)

4Ease of operation

If conventional two-dimensional cell cultures are used, then easy culture maintenance is achieved, but accurate modeling of drug responses in vivo is compromised

Engineering Contradiction:
Improveculture maintenance simplicityVSAvoidaccuracy of drug response modeling
Core Design Contradiction:
Ease of operationVSManufacturing precision

Solution Approach 1:

The patent transitions from two-dimensional cell cultures to three-dimensional nested droplet structures, adding the vertical dimension to cell arrangement. This dimensional change enables accurate modeling of in vivo drug responses while maintaining ease of operation through automated liquid handling and the self-contained nature of the nested structure, thus resolving the contradiction between simplicity and accuracy

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach allows for reliable, high-throughput screening of drug compounds by maintaining stable three-dimensional cell cultures for weeks, reducing errors and maintaining cell viability, and enabling consistent drug concentration administration and monitoring.

Implementation Method 1

An aqueous two-phase system for cell aggregates is provided. The aqueous two-phase system comprises: an immersion aqueous polymer phase; and, within the immersion aqueous polymer phase, a droplet of a droplet aqueous polymer phase containing a three-dimensional aggregate of cells.

Methodology Applied
Scientific EffectAqueous two-phase system: Two-Phase Flow

Data Source

PatentUS9874552B2Engineering individually addressable cellular spheroids using aqueous two-phase systems
Publication Date: 2018.01.23 THE UNIVERSITY OF AKRON
  • US9874552B2 patent drawing
  • US9874552B2 patent drawing
  • US9874552B2 patent drawing

AI summary

Provided are multi-phase systems that may be used to prepare a three-dimension aggregate of cells referred to as a cellular spheroid. The multi-phase system includes a droplet of an aqueous polymer phase within an immersion aqueous polymer phase. The droplet of the droplet aqueous polymer phase contains a three-dimensional aggregate of cells (cellular spheroid). Types of cells that may be used in the multi-phases system include stem cells and cancer cells. The cellular spheroids with the multi-phase system may be used to monitor cell growth in three-dimensional systems, or screen drugs in a three-dimension aggregate of cells.